CHRISTINE SWORDS: Open Payments
NPI 1003105727 · HINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 63 payments from 16 companies in 2025. Trend: 2023 $1,819 · 2024 $1,210 · 2025 $1,299
Food & beverage: $1,260Education: $39
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $242 |
| Travere Therapeutics, Inc. | 8 | $181 |
| Otsuka America Pharmaceutical, Inc. | 6 | $157 |
| Novartis Pharmaceuticals Corporation | 7 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $136 |
| Mallinckrodt Hospital Products Inc. | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| OPKO Pharmaceuticals, LLC | 3 | $58 |
| Averitas Pharma Inc. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: KRYSTEXXA, JYNARQUE, Fabhalta, Kerendia, ACTHAR, RAYALDEE, QUTENZA, LOKELMA.
Industry payments across GA — which companies pay providers there.
